Ketosome beta-hydroxybutyrate (BHB) inhibits the proliferation and growth of CRC by regulating the homologous domain protein Hopx on cancer cells, which requires the surface receptor Hcar to induce Hopx expression and inhibit the proliferation of intestinal epithelial cells [245]. The gene discussed is HOPX; the disease is cancer.